Related Experiment Video
Updated: Nov 17, 2025

Neonatal Murine Cochlear Explant Technique as an In Vitro Screening Tool in Hearing Research
Published on: June 8, 2017
Universal Neonatal Hearing Screening: An Experience at Tertiary Care Hospital
B L Shrestha1, S Karmacharya1, A Dhakal1
1Department of ENT-HNS, Dhulikhel Hospital, Kathmandu University Hospital, Kathmandu University School of Medical Sciences, Dhulikhel, Kavre, Nepal.
Insights
Automated Auditory Brainstem Response (AABR) effectively screens newborn hearing. Early AABR screening and intervention are crucial for preventing long-term hearing loss in infants.
Area of Science:
- Pediatric Audiology
- Neonatal Health
- Public Health Screening
Background:
- Congenital hearing loss is a significant pediatric health concern, often undetected early.
- Universal screening, diagnosis, and intervention are vital for mitigating the impact of neonatal hearing loss.
Purpose of the Study:
- To evaluate the effectiveness of Automated Auditory Brainstem Response (AABR) for hearing screening in newborns.
- To assess hearing outcomes in neonates admitted to the intensive care unit (NICU) at Dhulikhel Hospital.
Main Methods:
- A prospective study screened 5517 neonates using AABR within 24 hours of birth and at 6 weeks if initial screening failed.
- NICU neonates were assessed for risk factors according to the Joint Committee on Infant Hearing guidelines.
- Babies failing the second screening were referred for comprehensive audiological diagnostic workup.
Main Results:
- A 92.6% screening rate was achieved. 6.7% of screened neonates (374/5517) required referral after the second screening.
- Among referred neonates, 6.59% were well babies and 9% were NICU babies.
- Common risk factors included low birth weight, prematurity, hyperbilirubinemia, ototoxic medication use, and prolonged mechanical ventilation.
Conclusions:
- Automated Auditory Brainstem Response (AABR) is a valuable tool for neonatal hearing screening.
- Screening within the first month of life and timely intervention for confirmed hearing loss are recommended for improved future hearing outcomes.
Abstract:
Background Hearing loss among neonates is one of the important health issue in pediatric population which may remain unnoticed until the child reaches a certain age. The importance of universal early screening, diagnosis and intervention in reducing the negative impact of congenital hearing loss has been described all over the world. Objective To observe the outcome of hearing screening by Automated Auditory Brainstem Response (AABR) in newborns delivered in Dhulikhel Hospital and neonates admitted in an intensive care unit (NICU) of Dhulikhel Hospital. Method A prospective study was done in neonates who were born at Dhulikhel Hospital, Kathmandu University Hospital from February 15th, 2017 to October 30th, 2019. AABR was used for their hearing assessment within 24 hours of birth and again at about 6 weeks of age in those neonates who failed the initial test. All the neonates admitted in NICU were studied regarding the risk factors based on Joint committee on Infant Hearing. Those who failed the test for the second time were referred for detailed audiological diagnostic work up. Result The screening rate was 92.6% of the total deliveries. A total of 5517 neonates comprising of 2800 males and 2717 females were screened from total deliveries of 5956 neonates in the study period. Among them, NICU (sick) babies were 422 (7.7%) and well babies were 5095 (92.3%). Out of them, 1675 failed the test in the first screening and 374 failed in the second screening. So, the total number of referred babies in second screening was 6.7% (374) out of 5517 screened. Amongst them, well babies were 6.59% (336), out of 5095 screened and sick babies were 9% (38) out of 422 screened. Low birth weight and prematurity were found to be the commonest risk factor present among them, followed by the use of ototoxic medications, hyperbilirubinemia and prolonged use of mechanical ventilation. Conclusion Automated Auditory Brainstem Response (AABR) is a very useful tool for hearing screening which should preferably be done in all the neonates where possible. It should be done within one month of life and those with confirmed hearing loss should receive early appropriate intervention for better hearing in future.
Related Concept Videos
Tertiary Healthcare System
Hearing

